Rios Garcia, M. ; Meissburger, B.* ; Chan, J. ; de Guia, R.M.* ; Mattijssen, F. ; Roessler, S.* ; Birkenfeld, A.L. ; Raschzok, N.* ; Riols, F. ; Tokarz, J. ; Giroud, M. ; Gil Lozano, M. ; Hartleben, G. ; Nawroth, P.P. ; Haid, M. ; López, M.* ; Herzig, S. ; Berriel Diaz, M.
     
    
        
Trip13 depletion in liver cancer induces a lipogenic response contributing to plin2-dependent mitotic cell death.
    
    
        
    
    
        
        Adv. Sci. 9:e2104291 (2022)
    
    
    
      
      
	
	    Aberrant energy metabolism and cell cycle regulation both critically contribute to malignant cell growth and both processes represent targets for anticancer therapy. It is shown here that depletion of the AAA+-ATPase thyroid hormone receptor interacting protein 13 (Trip13) results in mitotic cell death through a combined mechanism linking lipid metabolism to aberrant mitosis. Diminished Trip13 levels in hepatocellular carcinoma cells result in insulin-receptor-/Akt-pathway-dependent accumulation of lipid droplets, which act as functional acentriolar microtubule organizing centers disturbing mitotic spindle polarity. Specifically, the lipid-droplet-coating protein perilipin 2 (Plin2) is required for multipolar spindle formation, induction of DNA damage, and mitotic cell death. Plin2 expression in different tumor cells confers susceptibility to cell death induced by Trip13 depletion as well as treatment with paclitaxel, a spindle-interfering drug commonly used against different cancers. Thus, assessment of Plin2 levels enables the stratification of tumor responsiveness to mitosis-targeting drugs, including clinically approved paclitaxel and Trip13 inhibitors currently under development.
	
	
	    
	
       
      
	
	    
		Impact Factor
		Scopus SNIP
		Web of Science
Times Cited
		Scopus
Cited By
		Altmetric
		
	     
	    
	 
       
      
     
    
        Publication type
        Article: Journal article
    
 
    
        Document type
        Scientific Article
    
 
    
        Thesis type
        
    
 
    
        Editors
        
    
    
        Keywords
        Mtocs ; Plin2 ; Trip13 ; Hepatocellular Carcinoma ; Lipogenesis ; Mitosis ; Spindle Assembly Checkpoint
    
 
    
        Keywords plus
        
    
 
    
    
        Language
        english
    
 
    
        Publication Year
        2022
    
 
    
        Prepublished in Year
        
    
 
    
        HGF-reported in Year
        2022
    
 
    
    
        ISSN (print) / ISBN
        2198-3844
    
 
    
        e-ISSN
        2198-3844
    
 
    
        ISBN
        
    
    
        Book Volume Title
        
    
 
    
        Conference Title
        
    
 
	
        Conference Date
        
    
     
	
        Conference Location
        
    
 
	
        Proceedings Title
        
    
 
     
	
    
        Quellenangaben
        
	    Volume: 9,  
	    Issue: 29,  
	    Pages: ,  
	    Article Number: e2104291 
	    Supplement: ,  
	
    
 
    
        
            Series
            
        
 
        
            Publisher
            Wiley
        
 
        
            Publishing Place
            Weinheim
        
 
	
        
            Day of Oral Examination
            0000-00-00
        
 
        
            Advisor
            
        
 
        
            Referee
            
        
 
        
            Examiner
            
        
 
        
            Topic
            
        
 
	
        
            University
            
        
 
        
            University place
            
        
 
        
            Faculty
            
        
 
    
        
            Publication date
            0000-00-00
        
 
         
        
            Application date
            0000-00-00
        
 
        
            Patent owner
            
        
 
        
            Further owners
            
        
 
        
            Application country
            
        
 
        
            Patent priority
            
        
 
    
        Reviewing status
        Peer reviewed
    
 
     
    
        POF-Topic(s)
        90000 - German Center for Diabetes Research
30505 - New Technologies for Biomedical Discoveries
30201 - Metabolic Health
    
 
    
        Research field(s)
        Helmholtz Diabetes Center
Enabling and Novel Technologies
    
 
    
        PSP Element(s)
        G-501900-253
G-501900-251
G-501900-252
G-502400-001
A-630710-001
G-502594-001
    
 
    
        Grants
        Ministerio de Economía y Competitividad (MINECO) co-funded by FEDER Program of EU
Helmholtz Future Topic AMPro
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2022-10-24